Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105

Completed

Conditions studied: Breast Cancer

In brief

RATIONALE: Studying samples of urine from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at urine samples from women with newly diagnosed breast cancer.

Key facts

Study ID

NCT00959244

Run by

University of Nebraska

People needed

100

Starts

2009-02-02

Expected to finish

2009-09-25

Last updated by the study team

2023-09-01

Who can join

Age: 19 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Newly diagnosed ductal carcinoma in situ or invasive breast cancer
• Urine biospecimens available from participation in protocol UNMC-08105 (IRB#311-06), the Breast Cancer Collaborative Registry (BCCR), which included treatment with tamoxifen or an aromatase inhibitor
• o Urine specimens were collected at baseline, 6 months, and then annually
• Estrogen receptor or progesterone receptor positive
• ECOG performance status 0-2

You may not qualify if…

• Not pregnant or nursing
• No concurrent use of estrogen(s)

Where it is running

• Eppley Cancer Center, University of Nebraska Medical Center — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.